Business
CFN Media Exclusive Interview: CURE Pharma Discusses Vision & Breakthrough Technology
CFN Media Exclusive Interview: CURE Pharma Discusses Vision & Breakthrough Technology.
About this update from Avenir Wellness Solutions Inc.
[{"type":"text","content":"\n \n \n CFN Media Exclusive Interview: CURE Pharma Discusses Vision & Breakthrough Technology\n \n \nCFN Media Exclusive Interview: CURE Pharma Discusses Vision & Breakthrough Technology\n \n SEATTLE, WA--(Marketwired - Aug 28, 2017) -  CFN Media Group (\"CFN Media\"), the leading agency and digital media network dedicated to legal cannabis, announces publication of an exclusive interview with CURE Pharmaceutical's (OTCQB: CURR) executive team: Robert Davidson, CEO and Chairman; Wayne Nasby, COO; and Jessica Rousset, CBO.\n CURE Pharmaceutical was founded by six individuals with experience in the pharmaceutical industry working with companies like Amgen Inc. and Merck & Co. Inc. With a focus on pediatrics and geriatrics, the company developed an oral thin film delivery system that it is used to address conditions ranging from cancer and its side effects to neurological diseases.\n The oral thin film technology, known as CureFilm™, is a proprietary toolbox of polymers designed to enhance the bioavailability of active pharmaceutical ingredients - or APIs. The combination of encapsulation methods and permeation enhancers enables APIs to bypass first-pass metabolism and effectively enter the bloodstream. This puts more APIs into the bloodstream and widens the therapeutic index via fewer side effects in the liver and GI tract.\n In addition to CureFilm™, the company has developed a vertically integrated operation capable of taking drugs from a pre-feasibility study all the way through manufacturing in a FDA-registered facility that's compliant with cGMP standards. \n CURE's current focus is on harnessing the potential of cannabinoids and terpenes to treat many underlying medical conditions, including cancer where it may cause apoptosis of cancer cells. Cannabinoids have also demonstrated strong potential in treating neurological conditions like Multiple Sclerosis, ALS, and Parkinson's disease, while improving cancer-related symptoms like pain, nausea, and appetite suppression.\n Please follow the link to see the interview: http://www.cannabisfn.com/exclusive-interview-cure-pharma-discusses-vision-breakthrough-technology/\n For more information, visit the company's website at www.curepharmaceutical.com.\n Learn how to become a CFN Media featured company, brand or entrepreneur: http://www.cannabisfn.com/be...